rs115332491

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006612.6(KIF1C):​c.2987G>A​(p.Ser996Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00385 in 1,518,520 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S996S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 43 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 73 hom. )

Consequence

KIF1C
NM_006612.6 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.833

Publications

6 publications found
Variant links:
Genes affected
KIF1C (HGNC:6317): (kinesin family member 1C) The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]
KIF1C-AS1 (HGNC:40324): (KIF1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017690659).
BP6
Variant 17-5023826-G-A is Benign according to our data. Variant chr17-5023826-G-A is described in ClinVar as Benign. ClinVar VariationId is 468856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0144 (2196/152220) while in subpopulation EAS AF = 0.0522 (269/5158). AF 95% confidence interval is 0.047. There are 43 homozygotes in GnomAd4. There are 1041 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1CNM_006612.6 linkc.2987G>A p.Ser996Asn missense_variant Exon 23 of 23 ENST00000320785.10 NP_006603.2 O43896
KIF1CXM_005256424.3 linkc.2987G>A p.Ser996Asn missense_variant Exon 24 of 24 XP_005256481.1 O43896

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1CENST00000320785.10 linkc.2987G>A p.Ser996Asn missense_variant Exon 23 of 23 1 NM_006612.6 ENSP00000320821.5 O43896
KIF1C-AS1ENST00000438266.2 linkn.172-2871C>T intron_variant Intron 1 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.0144
AC:
2185
AN:
152102
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0424
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00589
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.0524
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00915
AC:
1565
AN:
171012
AF XY:
0.00745
show subpopulations
Gnomad AFR exome
AF:
0.0453
Gnomad AMR exome
AF:
0.00120
Gnomad ASJ exome
AF:
0.00619
Gnomad EAS exome
AF:
0.0533
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000135
Gnomad OTH exome
AF:
0.00561
GnomAD4 exome
AF:
0.00268
AC:
3657
AN:
1366300
Hom.:
73
Cov.:
35
AF XY:
0.00247
AC XY:
1651
AN XY:
669546
show subpopulations
African (AFR)
AF:
0.0440
AC:
1327
AN:
30168
American (AMR)
AF:
0.00213
AC:
62
AN:
29156
Ashkenazi Jewish (ASJ)
AF:
0.00352
AC:
70
AN:
19914
East Asian (EAS)
AF:
0.0443
AC:
1714
AN:
38718
South Asian (SAS)
AF:
0.000920
AC:
65
AN:
70674
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49610
Middle Eastern (MID)
AF:
0.00265
AC:
14
AN:
5280
European-Non Finnish (NFE)
AF:
0.0000628
AC:
67
AN:
1066646
Other (OTH)
AF:
0.00602
AC:
338
AN:
56134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
219
438
656
875
1094
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0144
AC:
2196
AN:
152220
Hom.:
43
Cov.:
32
AF XY:
0.0140
AC XY:
1041
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0425
AC:
1767
AN:
41542
American (AMR)
AF:
0.00588
AC:
90
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.0522
AC:
269
AN:
5158
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
67972
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
111
222
333
444
555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0101
Hom.:
10
Bravo
AF:
0.0167
ESP6500AA
AF:
0.0434
AC:
189
ESP6500EA
AF:
0.000352
AC:
3
ExAC
AF:
0.00787
AC:
933
Asia WGS
AF:
0.0220
AC:
76
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 03, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32501971) -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIF1C: BS1, BS2 -

KIF1C-related disorder Benign:1
Sep 04, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Spastic ataxia 2 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Jan 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
13
DANN
Benign
0.95
DEOGEN2
Benign
0.069
T
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.51
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.83
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.42
N
REVEL
Benign
0.11
Sift
Benign
0.40
T
Sift4G
Benign
0.60
T
Polyphen
0.0010
B
Vest4
0.044
MVP
0.42
MPC
0.31
ClinPred
0.00080
T
GERP RS
0.20
Varity_R
0.022
gMVP
0.090
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115332491; hg19: chr17-4927121; COSMIC: COSV107347224; COSMIC: COSV107347224; API